Hepatic purine and pyrimidine metabolism: implications for antiviral chemotherapy of viral hepatitis
Authors:
- 1 August 1995
- journal article
- review article
- Published by Wiley in Liver International
- Vol. 15 (4) , 169-184
Abstract
The use of nucleoside analogues as antiviral agents is expanding. For most nucleoside analogues, intracellular phosphorylation is the major prerequisite for activity. Antiviral activity may be limited by poor uptake, absence of appropriate activating enzymes, catabolism, and competition from endogenous nucleotides. Appreciation of these factors, which are species‐, tissue‐ and cell‐specific is important in the understanding of the pharmacology and toxicology of nucleoside analogues. The use of nucleoside analogues against the agents of viral hepatitis is inherently problematic for many reasons including active hepatic nucleoside catabolism, probable absence of virus‐specific activating enzymes, competition from endogenous nucleotides synthesisedde novoor derived from RNA turnover, and factors related to mitochondrial toxicity. Despite these drawbacks, some nucleoside analogues have been found efficacious against hepatitis B virus and it is likely that as knowledge of their mechanism of action accumulates, their efficacy can be improved both by rational drug design and by use in combination with other drugs, including interferon.Keywords
This publication has 104 references indexed in Scilit:
- AZT Causes Tissue-Specific Inhibition of Mitochondrial Bioenergetic FunctionBiochemical and Biophysical Research Communications, 1993
- Selective assays for thymidine kinase 1 and 2 and deoxycytidine kinase and their activities in extracts from human cells and tissuesBiochemical and Biophysical Research Communications, 1992
- Mitochondrial endonuclease activity in the rat varies markedly among tissues in relation to the rate of tissue metabolismBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1991
- Massive conversion of guanosine to 8-hydroxy-guanosine in mouse liver mitochondrial DNA by administration of azidothymidineBiochemical and Biophysical Research Communications, 1991
- Once-Daily Administration of 2′,3′-Dideoxyinosine (ddI) in Patients with the Acquired Immunodeficiency Syndrome or AIDS-Related ComplexNew England Journal of Medicine, 1990
- Transition from cytosolic to mitochondrial thymidine kinase during development in human fetal tissuesLife Sciences, 1990
- Metaphysics of regulated deoxyribonucleotide biosynthesisMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1988
- Inhibition of HIV-associated reverse transcriptase by sugar-modified derivatives of thymidine 5′-triphosphate in comparison to cellular DNA polymerases α and βBiochemical and Biophysical Research Communications, 1987
- Thymine Salvage, Mitochondria, and the Evolution of the HerpesvirusesIntervirology, 1983
- Activation by thymidine kinase and potent antiherpetic activity of 2′-nor-2′-deoxyguanosine (2′NDG)Biochemical and Biophysical Research Communications, 1982